Pulse Biosciences, Inc Common Stock (DE) (PLSE) Stock Price

PLSEStock

$47.57+205.72%52W

Market Cap$3.39B

P/E—

PEG Ratio—

Div yield—

Beta1.56

PLSE Share Price Chart

Favorite Metrics

Price vs S&P 500 (26W)138.57%

Price vs S&P 500 (4W)24.54%

VGM Score44.34

Book Value / Share (Quarterly)$0.97

P/TBV (Annual)11.62x

Indicated Dividend (Annual)$0.00

Revenue Growth (3Y)-20.63%

Cash Flow / Share (Quarterly)$-0.81

Price vs S&P 500 (YTD)233.65%

Gross Margin (TTM)-21.04%

Net Profit Margin (TTM)-7376.70%

EPS (TTM)$-1.10

10-Day Avg Trading Volume0.37M

EPS Excl Extra (TTM)$-1.10

EPS (Annual)$-1.08

ROI (Annual)-90.24%

Gross Margin (Annual)-54.00%

Net Profit Margin (5Y Avg)-12111.99%

Cash / Share (Quarterly)$1.00

ROA (Last FY)-76.99%

EBITD / Share (TTM)$-1.15

ROE (5Y Avg)-125.64%

Operating Margin (TTM)-7692.41%

Cash Flow / Share (Annual)$-0.80

P/B Ratio48.49x

P/B Ratio (Quarterly)22.14x

Net Income / Employee (Annual)$-627,400

EV / Revenue (TTM)4189.34x

Net Interest Coverage (TTM)-129.02x

ROA (TTM)-73.61%

EPS Incl Extra (Annual)$-1.08

Current Ratio (Annual)10.53x

Quick Ratio (Quarterly)6.99x

3-Month Avg Trading Volume0.37M

52-Week Price Return205.72%

Revenue / Employee (TTM)$6,500

Tangible BV / Share (Quarterly)$0.97

P/S Ratio (Annual)9184.31x

Asset Turnover (Annual)0.00x

52-Week High$50.90

Operating Margin (5Y Avg)-12131.87%

EPS Excl Extra (Annual)$-1.08

CapEx CAGR (5Y)-5.31%

Tangible BV CAGR (5Y)25.05%

26-Week Price Return150.50%

Quick Ratio (Annual)10.22x

13-Week Price Return92.28%

Total Debt / Equity (Annual)0.00x

Current Ratio (Quarterly)7.26x

Enterprise Value$3.15B

Asset Turnover (TTM)0.01x

Book Value / Share Growth (5Y)-4.23%

Revenue / Employee (Annual)$3,000

Inventory Turnover (Annual)4.10x

Pretax Margin (Annual)-20794.57%

Cash / Share (Annual)$1.19

3-Month Return Std Dev65.14%

Net Income / Employee (TTM)$-642,800

ROE (Last FY)-90.24%

Net Interest Coverage (Annual)-51.91x

EPS Basic Excl Extra (Annual)$-1.08

Receivables Turnover (TTM)23.33x

Total Debt / Equity (Quarterly)0.00x

EPS Incl Extra (TTM)$-1.10

Receivables Turnover (Annual)22.95x

ROI (TTM)-86.67%

P/S Ratio (TTM)4280.31x

Pretax Margin (5Y Avg)-12111.99%

Revenue / Share (Annual)$0.01

Tangible BV / Share (Annual)$1.18

Price vs S&P 500 (52W)187.16%

Year-to-Date Return246.47%

5-Day Price Return-3.18%

EPS Normalized (Annual)$-1.08

ROA (5Y Avg)-76.26%

Net Profit Margin (Annual)-20794.57%

Month-to-Date Return35.41%

Cash Flow / Share (TTM)$-0.90

EBITD / Share (Annual)$-1.14

Operating Margin (Annual)-21982.57%

LT Debt / Equity (Annual)0.00x

ROI (5Y Avg)-125.20%

LT Debt / Equity (Quarterly)0.00x

EPS Basic Excl Extra (TTM)$-1.10

P/TBV (Quarterly)22.28x

P/B Ratio (Annual)11.54x

Inventory Turnover (TTM)7.70x

Pretax Margin (TTM)-7376.70%

Book Value / Share (Annual)$1.19

Price vs S&P 500 (13W)90.33%

Beta1.56x

Revenue / Share (TTM)$0.01

ROE (TTM)-86.67%

52-Week Low$12.56

vGradeF

mGradeA

vgmGradeC

PLSE Earnings Surprise History

Quarter	Report date	EPS estimate	EPS actual	Surprise
Q2 2026	Aug 6, 2026	-$0.28	-$0.28	+1.47%(+$0.00)
Q1 2026	May 4, 2026	-$0.22	-$0.24	-9.73%(-$0.02)
Q4 2025	Feb 19, 2026	-$0.21	-$0.18	+14.27%(+$0.03)
Q3 2025	Nov 5, 2025	-$0.31	-$0.29	+6.45%(+$0.02)
Q2 2025	Aug 12, 2025	-$0.26	-$0.28	-7.69%(-$0.02)

PLSE Analyst Recommendations

May 2026

Jun 2026

Jul 2026

Aug 2026

4.25

4.22

Industry Peers — Surgical & Medical Instruments(140)

Symbol	Value Score	Growth Score	Momentum Score	Price
PLSEPulse Biosciences, Inc Common Stock (DE)	F	—	A	$47.57
SYKStryker Corporation	C	B	C	$330.69
MMM3M Company	C	D	C	$174.34
BSXBoston Scientific Corp.	C	B	D	$46.84
BDXBecton, Dickinson and Co.	B	D	B	$189.52
MDLNMedline Inc. Class A common stock	C	D	C	$35.28
RMDResMed Inc.	C	B	B	$240.33
DXCMDexCom, Inc.	D	B	B	$90.82
WSTWest Pharmaceutical Services, Inc.	D	C	B	$337.47
SOLVSolventum Corporation	C	C	B	$91.12
BAXBaxter International Inc.	B	D	B	$26.13
PENPenumbra, Inc.	D	C	C	$321.68
GMEDGLOBUS MEDICAL INC	B	B	C	$82.97
GKOSGlaukos Corporation	F	A	A	$179.87
PODDInsulet Corporation	C	A	C	$145.13
TFXTeleflex Incorporated	B	F	B	$139.67
STVNStevanato Group S.p.A.	D	C	C	$21.03
MMEDMiniMed Group, Inc. Common Stock	—	—	A	$20.10
MMSIMerit Medical Systems Inc	C	B	B	$90.49
HAEHaemonetics Corporation	C	C	A	$103.96
ICUIICU Medical Inc	C	D	B	$175.10
HTFLHeartflow, Inc. Common Stock	—	A	B	$47.78
IRTCiRhythm Holdings, Inc. Common Stock	F	A	C	$120.25
ATRCAtriCure, Inc.	D	B	B	$48.54
UFPTUFP Technologies Inc	C	B	B	$300.05
NVCRNovoCure Limited Ordinary Shares	D	C	B	$17.82
LMATLeMaitre Vascular, Inc.	C	B	C	$80.45
INSPInspire Medical Systems, Inc.	B	B	B	$61.44
KMTSKestra Medical Technologies, Ltd. Common Stock	F	A	B	$25.64
TNDMTandem Diabetes Care, Inc.	D	C	B	$21.43
ATECAlphatec Holdings, Inc.	D	B	C	$9.44
DRTSAlpha Tau Medical Ltd. Ordinary Shares	—	—	A	$14.64
IARTIntegra LifeSciences Holdings	B	D	B	$16.89
AORTArtivion, Inc.	C	C	C	$26.77
PRCTPROCEPT BioRobotics Corporation Common Stock	C	A	D	$20.83
IRMDiRadimed Corporation	D	B	C	$87.07
BVSBioventus Inc. Class A Common Stock	B	C	A	$13.84
BBNXBeta Bionics, Inc. Common Stock	D	A	B	$19.72
SGPSpyGlass Pharma, Inc. Common Stock	—	—	B	$26.42
SIBNSI-BONE, Inc. Common Stock	D	B	B	$19.21
SSIISS Innovations International Inc. Common Stock	F	A	D	$3.48
MDXGMiMedx Group, Inc	C	D	C	$4.50
ANGOAngioDynamics, Inc.	C	D	A	$15.85
KIDSOrthoPediatrics Corp. Common Stock	C	B	B	$23.65
BWAYBrainsway Ltd. American Depositary Shares	F	A	B	$14.30
DCTHDelcath Systems Inc	D	B	A	$16.34
CERSCerus Corp	D	C	B	$2.65
TCMDTactile Systems Technology, Inc.	B	B	C	$23.16
NPCENeuropace, Inc. Common Stock	D	C	B	$14.41
CLPTClearPoint Neuro, Inc. Common Stock	F	A	B	$15.55
SGHTSight Sciences, Inc. Common Stock	D	B	A	$8.55

About Pulse Biosciences, Inc Common Stock (DE)

Pulse Biosciences develops Nano-Pulse Stimulation (NPS), a proprietary bioelectric medicine technology that uses precise nanosecond electrical pulses to remove diseased cells while preserving surrounding healthy tissue. The platform addresses multiple medical indications where current treatment options are insufficient or suboptimal. NPS represents a potentially transformative approach for treating conditions across various therapeutic areas.